Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age
- PMID: 25997508
- DOI: 10.1111/bjd.13923
Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age
Abstract
Background: Topical photodynamic therapy (PDT) is a popular treatment modality in dermatology. The effect of PDT in epidermal cells depends on formation of protoporphyrin IX (PpIX) from 5-aminolevulinic acid (ALA). A variety of physiological changes in epidermal function occur with increasing age, but no studies have investigated whether PpIX formation is age-related.
Objectives: To investigate a possible relationship between age and PpIX formation.
Methods: Methyl aminolaevulinate cream (MAL) and 5-ALA gel (BF-200 ALA) were applied to two identical fields on the forearm of 30 healthy volunteers for 24 h. The volunteers were divided into two age groups: a young group under 55 years (range 18-54) and an older group over 55 years (range 65-85). PpIX formation was measured noninvasively every hour from 1-5 h, and after 18, 21 and 24 h. Skin phototype, stratum corneum hydration and ultraviolet (UV) damage were also assessed. Treatment efficacy in relation to age was evaluated in 100 basal cell carcinomas (BCCs) treated with MAL-PDT.
Results: Both photosensitizers induced significantly more PpIX formation in the younger group. Linear regression revealed a significant age-related decline in PpIX formation after the standard application time of 3 h (P < 0.001 for both treatments). Skin phototype, stratum corneum hydration and UV damage were not associated with PpIX formation. The treatment efficacy of BCCs 3 months after MAL-PDT was higher in young patients (P = 0.012).
Conclusions: PpIX formation in human skin declines with age. No explanation could be attributed to skin phototype, stratum corneum hydration or UV damage. The consequence might be reduced efficacy of PDT in the elderly.
© 2015 British Association of Dermatologists.
Comment in
-
No age-related decline in efficacy of photodynamic therapy for treatment of basal cell carcinoma.Br J Dermatol. 2015 Dec;173(6):1564-5. doi: 10.1111/bjd.14080. Epub 2015 Nov 8. Br J Dermatol. 2015. PMID: 26286806 No abstract available.
Similar articles
-
Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.Br J Dermatol. 2009 Nov;161(5):1173-9. doi: 10.1111/j.1365-2133.2009.09437.x. Epub 2009 Aug 8. Br J Dermatol. 2009. PMID: 19785604
-
An investigation of the fluorescence induced by topical application of 5-aminolaevulinic acid and methyl aminolaevulinate at different body sites on normal human skin.Photodiagnosis Photodyn Ther. 2011 Jun;8(2):97-103. doi: 10.1016/j.pdpdt.2010.12.004. Epub 2011 Jan 15. Photodiagnosis Photodyn Ther. 2011. PMID: 21497300
-
Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.Br J Dermatol. 2006 Oct;155(4):791-9. doi: 10.1111/j.1365-2133.2006.07484.x. Br J Dermatol. 2006. PMID: 16965430
-
Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy.Dermatology. 2009;218(3):193-202. doi: 10.1159/000183753. Epub 2008 Dec 11. Dermatology. 2009. PMID: 19077380 Review.
-
Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models.Photodiagnosis Photodyn Ther. 2016 Sep;15:236-44. doi: 10.1016/j.pdpdt.2016.05.008. Epub 2016 Jun 7. Photodiagnosis Photodyn Ther. 2016. PMID: 27288253 Review.
Cited by
-
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy.Am J Clin Dermatol. 2024 Jan;25(1):99-118. doi: 10.1007/s40257-023-00829-w. Epub 2023 Dec 2. Am J Clin Dermatol. 2024. PMID: 38042767 Review.
-
Photodynamic Therapy in Pigmented Basal Cell Carcinoma-A Review.Biomedicines. 2023 Nov 20;11(11):3099. doi: 10.3390/biomedicines11113099. Biomedicines. 2023. PMID: 38002098 Free PMC article. Review.
-
How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications.Pharmaceuticals (Basel). 2021 Apr 6;14(4):333. doi: 10.3390/ph14040333. Pharmaceuticals (Basel). 2021. PMID: 33917339 Free PMC article.
-
Treatment of keratinocyte carcinoma in elderly patients - a review of the current literature.J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1932-1943. doi: 10.1111/jdv.16268. Epub 2020 Mar 30. J Eur Acad Dermatol Venereol. 2020. PMID: 32030838 Free PMC article. Review.
-
Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.PLoS One. 2019 Apr 24;14(4):e0215537. doi: 10.1371/journal.pone.0215537. eCollection 2019. PLoS One. 2019. PMID: 31017970 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
